The study cited above shows that the mutation of IDH1 in GBM results in an increase in SCD expression (increase in the amount of MUFA) and probably an increase in FADS1 expression, but it does not affect the expression of FADS2 (no effect on the overall PUFA level). Here, FADS2 is linked to glioblastoma.